MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls
Lilin He, Yongxiang Shen Department of Oncology, The First People’s Hospital of Tianmen City, Tianmen, Hubei Province, People’s Republic of China Objective: Previous studies have found that many gene variations can be detected in both breast cancer and ovarian cancer, which is...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-01-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/mthfr-c677t-polymorphism-and-breast-ovarian-cancer-risk--a-meta-analys-peer-reviewed-article-OTT |